transferrin has been researched along with Bone Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inui, M; Kamei, T; Nakamura, S; Nakase, M; Okumura, K; Tagawa, T | 1 |
| Abhyankar, A; Awasare, S; Basu, S; Kaisar, S; Rani, D | 1 |
2 other study(ies) available for transferrin and Bone Cancer
| Article | Year |
|---|---|
p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome.
Topics: Animals; bcl-2-Associated X Protein; Blotting, Western; Bone Neoplasms; Cations; Cell Line, Tumor; DNA Mutational Analysis; Female; Gene Transfer Techniques; Genes, p53; Genetic Therapy; Genetic Vectors; Humans; In Situ Nick-End Labeling; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Mutation; Neoplasm Transplantation; Osteosarcoma; Plasmids; Proto-Oncogene Proteins c-bcl-2; Receptors, Transferrin; Time Factors; Transferrin; Tumor Suppressor Protein p53 | 2005 |
Examining recombinant human TSH primed ¹³¹I therapy protocol in patients with metastatic differentiated thyroid carcinoma: comparison with the traditional thyroid hormone withdrawal protocol.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Humans; Iodine Radioisotopes; Lung Neoplasms; Middle Aged; Thyroid Hormones; Thyroid Neoplasms; Thyrotropin Alfa; Young Adult | 2014 |